Bio-Rad Laboratories, Inc. Share Price Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
01:25:01 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 331.00 EUR | -0.96% |
|
-0.72% | +29.40% |
| 07/08 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 05/08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
| Market Cap | 1.02TCr 879.21Cr 827.21Cr 755.66Cr 1.41TCr 96TCr 1.42TCr 9.77TCr 3.79TCr 49TCr 3.84TCr 3.75TCr 1,59500Cr | P/E 2026 * |
46.4x | P/E 2027 * | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 946.84Cr 814.76Cr 766.57Cr 700.27Cr 1.31TCr 89TCr 1.31TCr 9.06TCr 3.52TCr 46TCr 3.56TCr 3.48TCr 1,47800Cr | EV / Sales 2026 * |
3.68x | EV / Sales 2027 * | 3.51x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO | Delayed | |
CBOE
| BIO | Real-time | |
|
Boerse Muenchen
| BUWA | Real-time | |
|
Tradegate
| BUWA | Real-time | |
|
Börse Stuttgart
| BUWA | Delayed | |
|
Deutsche Boerse AG
| BUWA | Delayed |
Last Transcript : Bio-Rad Laboratories, Inc.
| 1 day | -0.96% | ||
| 1 week | -0.72% | ||
| Current month | -0.54% | ||
| 1 month | +14.93% | ||
| 3 months | +25.95% | ||
| 6 months | +35.66% | ||
| Current year | +29.40% |
| 1 week | 322.4 |  | 334.8 |
| 1 month | 289.2 | | 338.4 |
| Current year | 204.6 | | 338.4 |
| 1 year | 204.6 | | 338.4 |
| 3 years | 187.35 | | 355.2 |
| 5 years | 187.35 | | 700 |
| 10 years | 133.36 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -0.72% | - | - | 1.02TCr | |
| -0.42% | -3.68% | -18.43% | +5.33% | 19TCr | |
| +1.15% | +3.22% | +1.42% | +14.66% | 12TCr | |
| -1.86% | +2.77% | +13.07% | +89.16% | 6.32TCr | |
| -1.31% | -1.09% | +22.44% | +46.84% | 5.17TCr | |
| -1.54% | -2.52% | -3.41% | -33.66% | 5.03TCr | |
| -2.02% | -3.22% | +8.84% | -13.73% | 3.32TCr | |
| 0.00% | +3.71% | - | - | 3.21TCr | |
| -0.81% | +0.74% | +37.34% | -16.61% | 2.39TCr | |
| -1.44% | -4.21% | -7.37% | +11.97% | 2.3TCr | |
| Average | -0.92% | -0.07% | +6.74% | +12.99% | 6.5TCr | |
| Weighted average by Cap. | -0.56% | +0.02% | -0.82% | +15.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 257.33Cr 221.43Cr 208.34Cr 190.32Cr 356.03Cr 24TCr 357Cr 2.46TCr 955.32Cr 12TCr 966.31Cr 945.23Cr 40TCr | 263.35Cr 226.61Cr 213.21Cr 194.77Cr 364.35Cr 25TCr 365.34Cr 2.52TCr 977.66Cr 13TCr 988.9Cr 967.34Cr 41TCr |
| Net income | 22Cr 19Cr 18Cr 17Cr 31Cr 2.12TCr 31Cr 215.26Cr 84Cr 1.09TCr 84Cr 83Cr 3.51TCr | 23Cr 20Cr 19Cr 17Cr 32Cr 2.17TCr 32Cr 220.04Cr 85Cr 1.11TCr 86Cr 84Cr 3.59TCr |
| Net Debt | -75Cr -64Cr -61Cr -55Cr -103.63Cr -7.07TCr -103.91Cr -716.58Cr -278.07Cr -3.63TCr -281.26Cr -275.13Cr -12TCr | -97Cr -83Cr -78Cr -71Cr -133.57Cr -9.12TCr -133.93Cr -923.61Cr -358.4Cr -4.68TCr -362.52Cr -354.62Cr -15TCr |
| Date | Price | Change |
|---|---|---|
| 04/26/04 | €331.00 | -0.96% |
| 03/26/03 | €334.20 | -0.18% |
| 02/26/02 | €334.80 | +2.14% |
| 01/26/01 | €327.80 | -1.50% |
| 31/26/31 | €332.80 | -0.18% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Select your edition
All financial news and data tailored to specific country editions
